Cargando…

Histone deacetylase inhibition leads to regulatory histone mark alterations and impairs meiosis in oocytes

BACKGROUND: Panobinostat (PB), a histone deacetylase (HDAC) inhibitor drug, is clinically used in the treatment of cancers. We investigated the effects of PB on murine ovarian functions in embryos and adult animals. METHODS: C57BL/6J mice were treated with 5 mg/kg PB on alternate days from embryonic...

Descripción completa

Detalles Bibliográficos
Autores principales: Legoff, Louis, Dali, Ouzna, De La Mata Santaella, Elena, Jaulin, Christian, D’Cruz, Shereen Cynthia, Smagulova, Fatima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359552/
https://www.ncbi.nlm.nih.gov/pubmed/34384478
http://dx.doi.org/10.1186/s13072-021-00413-8
_version_ 1783737571281469440
author Legoff, Louis
Dali, Ouzna
De La Mata Santaella, Elena
Jaulin, Christian
D’Cruz, Shereen Cynthia
Smagulova, Fatima
author_facet Legoff, Louis
Dali, Ouzna
De La Mata Santaella, Elena
Jaulin, Christian
D’Cruz, Shereen Cynthia
Smagulova, Fatima
author_sort Legoff, Louis
collection PubMed
description BACKGROUND: Panobinostat (PB), a histone deacetylase (HDAC) inhibitor drug, is clinically used in the treatment of cancers. We investigated the effects of PB on murine ovarian functions in embryos and adult animals. METHODS: C57BL/6J mice were treated with 5 mg/kg PB on alternate days from embryonic day (E) 6.5 to E15.5. We analysed the effects of PB on the ovaries by using immunofluorescence, gene expression analysis and DNA methylation analysis techniques. RESULTS: At E15.5, we observed increases in histone H3K9Ac, H4Ac and H3K4me3 marks, while the level of the silencing H3K9me3 mark decreased. Synaptonemal complex examination at E15.5, E17.5 and E18.5 showed a delay in meiotic progression characterized by the absence of synaptonemal complexes at E15.5 and the persistence of double-strand breaks (DSBs) at E17.5 and E18.5 in PB-exposed oocytes. We found that exposure to PB led to changes in the expression of 1169 transcripts at E15.5. Genes regulated by the male-specific factors SRY-Box Transcription Factor 9 (SOX9) and Doublesex and Mab-3-related Transcription factor 1 (DMRT1) were among the most upregulated genes in the ovaries of PB-exposed mice. In contrast, PB treatment led to decreases in the expression of genes regulated by the WNT4 pathway. Notably, we observed 119 deregulated genes encoding Zn-finger proteins. The observed alterations in epigenetic marks and gene expression correlated with decreases in the numbers of germ cells at E15.5. After birth, PB-exposed ovaries showed increased proliferation of primary and secondary follicles. We also observed decreases in the numbers of primordial, primary and secondary follicles in adult ovaries from mice that were exposed to PB in utero. Finally, epigenetic alterations such as decreased H3K4me3 and increased H4 acetylation levels were also detected in somatic cells surrounding fully grown oocytes. CONCLUSION: Our data suggest that inhibition of histone deacetylase by PB during a critical developmental window affects reprogramming and germ cell specification via alteration of epigenetic marks. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13072-021-00413-8.
format Online
Article
Text
id pubmed-8359552
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83595522021-08-16 Histone deacetylase inhibition leads to regulatory histone mark alterations and impairs meiosis in oocytes Legoff, Louis Dali, Ouzna De La Mata Santaella, Elena Jaulin, Christian D’Cruz, Shereen Cynthia Smagulova, Fatima Epigenetics Chromatin Research BACKGROUND: Panobinostat (PB), a histone deacetylase (HDAC) inhibitor drug, is clinically used in the treatment of cancers. We investigated the effects of PB on murine ovarian functions in embryos and adult animals. METHODS: C57BL/6J mice were treated with 5 mg/kg PB on alternate days from embryonic day (E) 6.5 to E15.5. We analysed the effects of PB on the ovaries by using immunofluorescence, gene expression analysis and DNA methylation analysis techniques. RESULTS: At E15.5, we observed increases in histone H3K9Ac, H4Ac and H3K4me3 marks, while the level of the silencing H3K9me3 mark decreased. Synaptonemal complex examination at E15.5, E17.5 and E18.5 showed a delay in meiotic progression characterized by the absence of synaptonemal complexes at E15.5 and the persistence of double-strand breaks (DSBs) at E17.5 and E18.5 in PB-exposed oocytes. We found that exposure to PB led to changes in the expression of 1169 transcripts at E15.5. Genes regulated by the male-specific factors SRY-Box Transcription Factor 9 (SOX9) and Doublesex and Mab-3-related Transcription factor 1 (DMRT1) were among the most upregulated genes in the ovaries of PB-exposed mice. In contrast, PB treatment led to decreases in the expression of genes regulated by the WNT4 pathway. Notably, we observed 119 deregulated genes encoding Zn-finger proteins. The observed alterations in epigenetic marks and gene expression correlated with decreases in the numbers of germ cells at E15.5. After birth, PB-exposed ovaries showed increased proliferation of primary and secondary follicles. We also observed decreases in the numbers of primordial, primary and secondary follicles in adult ovaries from mice that were exposed to PB in utero. Finally, epigenetic alterations such as decreased H3K4me3 and increased H4 acetylation levels were also detected in somatic cells surrounding fully grown oocytes. CONCLUSION: Our data suggest that inhibition of histone deacetylase by PB during a critical developmental window affects reprogramming and germ cell specification via alteration of epigenetic marks. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13072-021-00413-8. BioMed Central 2021-08-12 /pmc/articles/PMC8359552/ /pubmed/34384478 http://dx.doi.org/10.1186/s13072-021-00413-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Legoff, Louis
Dali, Ouzna
De La Mata Santaella, Elena
Jaulin, Christian
D’Cruz, Shereen Cynthia
Smagulova, Fatima
Histone deacetylase inhibition leads to regulatory histone mark alterations and impairs meiosis in oocytes
title Histone deacetylase inhibition leads to regulatory histone mark alterations and impairs meiosis in oocytes
title_full Histone deacetylase inhibition leads to regulatory histone mark alterations and impairs meiosis in oocytes
title_fullStr Histone deacetylase inhibition leads to regulatory histone mark alterations and impairs meiosis in oocytes
title_full_unstemmed Histone deacetylase inhibition leads to regulatory histone mark alterations and impairs meiosis in oocytes
title_short Histone deacetylase inhibition leads to regulatory histone mark alterations and impairs meiosis in oocytes
title_sort histone deacetylase inhibition leads to regulatory histone mark alterations and impairs meiosis in oocytes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359552/
https://www.ncbi.nlm.nih.gov/pubmed/34384478
http://dx.doi.org/10.1186/s13072-021-00413-8
work_keys_str_mv AT legofflouis histonedeacetylaseinhibitionleadstoregulatoryhistonemarkalterationsandimpairsmeiosisinoocytes
AT daliouzna histonedeacetylaseinhibitionleadstoregulatoryhistonemarkalterationsandimpairsmeiosisinoocytes
AT delamatasantaellaelena histonedeacetylaseinhibitionleadstoregulatoryhistonemarkalterationsandimpairsmeiosisinoocytes
AT jaulinchristian histonedeacetylaseinhibitionleadstoregulatoryhistonemarkalterationsandimpairsmeiosisinoocytes
AT dcruzshereencynthia histonedeacetylaseinhibitionleadstoregulatoryhistonemarkalterationsandimpairsmeiosisinoocytes
AT smagulovafatima histonedeacetylaseinhibitionleadstoregulatoryhistonemarkalterationsandimpairsmeiosisinoocytes